Deciphering the Genetic Code of Autoimmune Kidney Diseases

Genes (Basel). 2023 Apr 30;14(5):1028. doi: 10.3390/genes14051028.

Abstract

Autoimmune kidney diseases occur due to the loss of tolerance to self-antigens, resulting in inflammation and pathological damage to the kidneys. This review focuses on the known genetic associations of the major autoimmune kidney diseases that result in the development of glomerulonephritis: lupus nephritis (LN), anti-neutrophil cytoplasmic associated vasculitis (AAV), anti-glomerular basement disease (also known as Goodpasture's disease), IgA nephropathy (IgAN), and membranous nephritis (MN). Genetic associations with an increased risk of disease are not only associated with polymorphisms in the human leukocyte antigen (HLA) II region, which governs underlying processes in the development of autoimmunity, but are also associated with genes regulating inflammation, such as NFkB, IRF4, and FC γ receptors (FCGR). Critical genome-wide association studies are discussed both to reveal similarities in gene polymorphisms between autoimmune kidney diseases and to explicate differential risks in different ethnicities. Lastly, we review the role of neutrophil extracellular traps, critical inducers of inflammation in LN, AAV, and anti-GBM disease, where inefficient clearance due to polymorphisms in DNase I and genes that regulate neutrophil extracellular trap production are associated with autoimmune kidney diseases.

Keywords: IgA nephropathy anti-glomerular basement disease; anti-neutrophil cytoplasmic antibody vasculitis; gene mutations; glomerulonephritis; inflammation; lupus nephritis; neutrophil extracellular traps.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Glomerular Basement Membrane Disease* / pathology
  • Autoimmune Diseases*
  • Genetic Code
  • Genome-Wide Association Study
  • Humans
  • Inflammation / pathology
  • Kidney / pathology
  • Kidney Diseases* / genetics
  • Kidney Diseases* / pathology
  • Kidney Glomerulus / pathology

Grants and funding

Kim M. O’Sullivan is funded by the Australian National Health and Medical Research Council (NHMRC) Ideas, Grant ID number 2001325.